Skip to content

The Effectiveness of Psychological Therapy on Improving Psychological Symptoms in Patients with Multiple Sclerosis

Comparison of the Effectiveness of Acceptance and Commitment Therapy (ACT) with Cognitive-Behavioral Therapy (CBT) in Improving Psychological Symptoms in Multiple Sclerosis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016112631115N1
Enrollment
66
Registered
2017-09-13
Start date
2016-12-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Multiple Sclerosis. Condition 2: Fatigue. Condition 3: Depression. Condition 4: Stress. Condition 5: Anxiety. General physical deterioration, Lethargy, Tiredness Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities. A transient disorder that develops in an individual without any other apparent mental disorder in response to exceptional physical and mental stress and that usual

Interventions

Intervention 1: Acceptance & Commitment Therapy(ACT). Intervention 2: Cognitive-Behavior Therapy(CBT). Intervention 3: No intervention.
Behavior
Acceptance & Commitment Therapy(ACT)
Cognitive-Behavior Therapy(CBT)
No intervention

Sponsors

Vice chancellor for research of Baqiatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-20-40 years old-rage 2-Ability of orderly participation in therapy sessions 3-Conscious satisfaction of participation in research plan 1-Having serious signs of MS 2-Affliction to or suffering from extreme or serious physical or mental disease 3-Not intend to participation in therapy process

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: Before the intervention (pre-test), immediately after the intervention (post-test), after one month and half of the intervention (follow-up 1), after three month of the intervention(follow-up 2). Method of measurement: Based on Fatigue in M.S patient Questionnaire.;Depresiion. Timepoint: Before the intervention (pre-test), immediately after the intervention (post-test), after one month and half of the intervention (follow-up 1), after three month of the intervention(follow-up 2). Method of measurement: Depression, Anxiety & Stress Scale(DASS).;Anxiety. Timepoint: Before the intervention (pre-test), immediately after the intervention (post-test), after one month and half of the intervention (follow-up 1), after three month of the intervention(follow-up 2). Method of measurement: Depression, Anxiety & Stress Scale(DASS).;Stress. Timepoint: Before the intervention (pre-test), immediately after the intervention (post-test), after one month and half of the intervention (follow-up 1), after three month of the intervention(follow-up 2). Method of measurement: Depression, Anxiety & Stress Scale(DASS).

Secondary

MeasureTime frame
Resilience. Timepoint: Before the intervention (pre-test), immediately after the intervention (post-test), after one month and half of the intervention (follow-up 1), after three month of the intervention(follow-up 2). Method of measurement: Connor- Davidson Resilience Scale.;Quality of Life. Timepoint: Before the intervention (pre-test), immediately after the intervention (post-test), after one month and half of the intervention (follow-up 1), after three month of the intervention(follow-up 2). Method of measurement: M.s Quality of Life scale.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmohsen karimi

Baqiatallah University of Medical Sciences

moh3en.karimi@yahoo.com+98 31 5264 3283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026